Automated Author ProfileElias, Pierre
Columbia University Medical Center
Elias, Pierre
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 3.6 (sum of 2 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
Existing chest radiograph datasets, such as CheXpert and ChestX-ray14, havedriven the development of new machine learning approaches to achieve expert ornear-expert level performance on a variety of tasks. The primary focus ofmodels developed using these datasets has been to replicate human-levelperformance by training on labels computationally extracted from radiologyreports. We propose a different paradigm: pair an existing diagnostic testwith labels from a more accurate, higher fidelity diagnostic test. Thisapproach seeks to ask whether data from a cheaper, lower fidelity diagnostictest contains information for detection of pathologies using more accurate,gold standard labels. In the context of chest X-rays, a good example is theradiologic comment of cardiomegaly, a catch-all term or an abnormally enlargedheart. Cardiomegaly is known to be poorly predictive of cardiac disease anddoes not trigger meaningful clinical action. Instead, we can pair chest X-rayswith gold standard structural heart disease labels derived fromechocardiograms conducted on the same patients. This resource contains 71,589unique chest X-rays from 24,689 different patients paired with keyechocardiography measurements indicative of left ventricular hypertrophy anddilated left ventricle, pathologies which occur during early stage heartfailure. The data also includes information about the relative times of thechest X-rays, the age/sex of the patient at the time of recording, and relatedmetadata information. This data can be used as a resource for the community tobuild novel approaches to detect clinically actionable labels.
Authors
- Elias, Pierre ;
- Bhave, Shreyas
Existing chest radiograph datasets, such as CheXpert and ChestX-ray14, havedriven the development of new machine learning approaches to achieve expert ornear-expert level performance on a variety of tasks. The primary focus ofmodels developed using these datasets has been to replicate human-levelperformance by training on labels computationally extracted from radiologyreports. We propose a different paradigm: pair an existing diagnostic testwith labels from a more accurate, higher fidelity diagnostic test. Thisapproach seeks to ask whether data from a cheaper, lower fidelity diagnostictest contains information for detection of pathologies using more accurate,gold standard labels. In the context of chest X-rays, a good example is theradiologic comment of cardiomegaly, a catch-all term or an abnormally enlargedheart. Cardiomegaly is known to be poorly predictive of cardiac disease anddoes not trigger meaningful clinical action. Instead, we can pair chest X-rayswith gold standard structural heart disease labels derived fromechocardiograms conducted on the same patients. This resource contains 71,589unique chest X-rays from 24,689 different patients paired with keyechocardiography measurements indicative of left ventricular hypertrophy anddilated left ventricle, pathologies which occur during early stage heartfailure. The data also includes information about the relative times of thechest X-rays, the age/sex of the patient at the time of recording, and relatedmetadata information. This data can be used as a resource for the community tobuild novel approaches to detect clinically actionable labels.
Authors
- Elias, Pierre ;
- Bhave, Shreyas